| Symbol | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | h-rank |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIIB | 27 B | 10.0 | 2.7 | 27.00 | 30 | 33 | 2.8 | 19 | 20 | 1 | 22 |
| BMY | 106 B | 7.4 | 1.3 | 8.11 | 31 | 40 | 2.8 | 80 | 22 | 1 | 28 |
| GILD | 150 B | 16 | 1.5 | 6.84 | 45 | 48 | 3.0 | 143 | 22 | 1 | 47 |
| MRK | 249 B | 10.0 | 1.7 | 7.34 | 40 | 49 | 3.7 | 87 | 21 | 1 | 22 |
| AMGN | 178 B | 15 | 1.3 | 17.54 | 34 | 45 | 12 | 13 | 22 | 2 | 34 |
| AZN | 280 B | 16 | 0.88 | 5.28 | 24 | 35 | 12 | 78 | 23 | 2 | 46 |
| JNJ | 487 B | 19 | 1.1 | 7.70 | 30 | 34 | 6.8 | 91 | 24 | 2 | 42 |
| LLY | 906 B | 44 | 1.5 | 11.07 | 48 | 48 | 53 | 480 | 18 | 2 | 39 |
| NVO | 213 B | 11 | 0.78 | 7.33 | 44 | 52 | 5.1 | -26 | 25 | 2 | 34 |
| NVS | 254 B | 15 | 0.88 | 5.04 | 31 | 44 | 9.0 | 28 | 24 | 2 | 55 |
| OGN | 1.9 B | 1.7 | 1.8 | 2.58 | 23 | 26 | 1.3 | -55 | 23 | 2 | 41 |
| PFE | 148 B | 8.9 | 1.3 | 2.64 | 35 | 38 | -5.9 | -21 | 25 | 2 | 38 |
| ABBV | 400 B | 18 | 0.72 | 3.21 | 35 | 49 | 9.1 | -88 | 26 | 3 | 50 |
| SNY | 121 B | 10.0 | 1.1 | 7.31 | 28 | 26 | -7.0 | 2.4 | 27 | 3 | 54 |
| GRFS | 7.3 B | 7.9 | 2.5 | 1.21 | 20 | 23 | 4.0 | 30 | 5 | 47 | |
| GSK | 98 B | 11 | 0.84 | 0.82 | 32 | 29 | 6.7 | 33 | 5 | 53 | |
| MIRA | 61 M | -3.0 | 90 | 0.18 | 0.00 | 0.00 | 47 | 21 | 47 | ||
| AMRN | 344 M | -78 | 3.4 | 0.69 | -3.4 | -10.0 | 17 | 59 | 29 | 64 | |
| MDCX | 45 M | -1.4 | 0.92 | 0.39 | 0.00 | 0.00 | 60 | 31 | 71 | ||
| NSRX | 62 M | 0.12 | 0.04 | 0.00 | 0.00 | 71 | 45 | 79 | |||
| SCLX | 117 M | -49 | 0.05 | 0.15 | -1766 | 0.00 | -26 | 73 | 49 | 49 | |
| Q1=10.0 | Q3=1.7 | Q3=35.0 | Q3=45.0 | Q3=9.1 | Q3=87.0 | Q1=38.0 |
| Total Records: 21. | Quotes | Help |
| © George Elgin | Questions or Comments | Data last Modified 12/06/25 |